Cargando…
Development and Characterization of a Nanobody against Human T-Cell Immunoglobulin and Mucin-3
Monoclonal antibodies and antibody-derived biologics are essential tools for cancer research and therapy. The development of monoclonal antibody treatments for successful tumor-targeted therapies took several decades. A nanobody constructed by molecular engineering of heavy-chain-only antibody, whic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206550/ https://www.ncbi.nlm.nih.gov/pubmed/35726228 http://dx.doi.org/10.1155/2022/2929605 |